Financials
Insurance Brokers
$30.98B
48K
Key insights and themes extracted from this filing
While as-reported revenue decreased by $4 million for the three months and $122 million for the six months ended June 30, 2025, primarily due to the sale of TRANZACT, organic revenue grew by 5% for both periods. This organic growth was driven by strong performances across both the Health, Wealth & Career (HWC) and Risk & Broking (R&B) segments, indicating underlying business strength.
Income from operations for the three months ended June 30, 2025, increased to $368 million (16% of revenue) from $212 million (9% of revenue) in the prior year, a 73.6% increase. Net income attributable to WTW surged by 135% to $331 million for the quarter, largely due to lower marketing, transformation, and transaction costs following the completion of the Transformation program.
Net cash from operating activities for the six months ended June 30, 2025, decreased to $326 million from $431 million in the prior year, a 24.3% reduction. Free cash flow also declined by 28.9% to $217 million, primarily driven by increased compensation, higher cash tax payments, and the absence of cash inflows from the TRANZACT business post-sale.